InfuSystem Holdings (INFU) Research & Development (2010 - 2026)

InfuSystem Holdings (INFU) has reported Research & Development for 17 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 10.54% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $10.9 million (up 2.68% YoY), and the FY2025 full-year result was $10.5 million, down 7.29% from the prior year.
• Research & Development eased to $3.0 million in Q2 2026 per INFU's latest filing, from $3.1 million in the prior quarter.
• Across five years, Research & Development topped out at $3.7 million in Q4 2023 and bottomed at $2.1 million in Q4 2024.
• Historically, Research & Development has averaged $2.9 million across 5 years, with a median of $3.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Research & Development surged 39.69% in 2022, then slumped 42.45% in 2024.
• Over 5 years, Research & Development stood at $3.0 million in 2022, then advanced by 25.45% to $3.7 million in 2023, then plunged by 42.45% to $2.1 million in 2024, then advanced by 13.7% to $2.4 million in 2025, then increased by 22.9% to $3.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $3.0 million, $3.1 million, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.